Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Johnson and Johnson
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Fish and Richardson

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,063,802

« Back to Dashboard

Summary for Patent: 6,063,802

Title: Ondansetron freeze-dried dosage form compositions for oral administration
Abstract:The invention relates to a freeze-dried dosage form for oral administration capable of being rapidly disintegrated in the mouth comprising ondansetron in the form of its free base or a pharmaceutically acceptable solvate thereof and one or more pharmaceutically acceptable excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5HT) at 5HT.sub.3 receptors are also described.
Inventor(s): Winterborn; Ian Keith (Ware, GB)
Assignee: Glaxco Wellcome Inc. (Mississauga, CA)
Application Number:09/238,165
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 6,063,802

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9423511Nov 22, 1994

International Patent Family for Patent: 6,063,802

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom9523667► Subscribe
United Kingdom2295318► Subscribe
France2727016► Subscribe
Finland119355► Subscribe
Finland972167► Subscribe
Spain2147309► Subscribe
European Patent Office0793495► Subscribe
Czech Republic285250► Subscribe
Denmark0793495► Subscribe
Germany69517332► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: